Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Cytek Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +15 vs. Q3 2022
- Shares held
- 64.1M
- +3.02M (+4.9%) vs. Q3 2022
- Total value
- $654.1M
- −$244.4M (−27.2%) vs. Q3 2022
- New holders
- 25
- 42 more added
- Sold out
- 10
- 24 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTKB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $361.0M |
| Q1 2026 | 165 | $371.8M |
| Q4 2025 | 155 | $414.3M |
| Q3 2025 | 153 | $277.4M |
| Q2 2025 | 158 | $270.0M |
| Q1 2025 | 161 | $310.8M |
| Q4 2024 | 153 | $501.4M |
| Q3 2024 | 136 | $415.3M |
| Q2 2024 | 129 | $425.1M |
| Q1 2024 | 125 | $540.9M |
| Q4 2023 | 105 | $719.9M |
| Q3 2023 | 107 | $427.7M |
| Q2 2023 | 101 | $657.9M |
| Q1 2023 | 102 | $629.6M |
| Q4 2022 | 103 | $654.1M |
| Q3 2022 | 88 | $898.5M |
| Q2 2022 | 85 | $567.8M |
| Q1 2022 | 74 | $514.5M |
| Q4 2021 | 52 | $571.9M |
| Q3 2021 | 54 | $733.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cytek Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 8,367,607 | $85.4M | 0.00% | +449,965+5.7% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 8,684,530 | $88.7M | 1.87% | −72,500−0.8% | Reduced |
| Ra Capital Management, L.P. | 13,381,054 | $136.6M | 2.77% | 00.0% | Unchanged |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −67,084−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −41,750−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −40,559−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −31,981−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −31,163−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −12,568−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −11,253−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −7,210−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |